Utility of Individualised Homoeopathic Medicine in Treatment of Polycystic Ovarian Syndrome - A Case Series
Abstract
Introduction: Polycystic ovarian syndrome (PCOS) is one the most common endocrinological pathology of female reproductive organs especially in reproductive age group. According to WHO currently 8-13% females are suffering from PCOS worldwide while, 70% of the cases remain undiagnosed. The seriousness of the disease is attributed to it for being a leading cause of female infertility due to anovulation. The comprehensive effect of hyperandrogenism and menstrual irregularities leads to adverse psychological consequences in a female’s life. Its conventional treatment includes diet management, combined-oral contraceptive pills (OCPs), dexamethasone, metformin etc. which may have side-effects like increased weight, nausea, vomiting, thrombosis and many more. Alternative medicine like Homoeopathic treatment with Individualised and holistic approach can provide a gentle management for PCOS. This article contains a series of four cases showing successful treatment of PCOS and emphasizes its effectiveness as a potential alternative to present conventional medicines available for PCOS.
Conclusion: Homoeopathic treatment was given with Individualised medicines which were selected exclusively in each case. This treated PCOS in a gentle and short frame of time in all four cases. The medicines prescribed were Pulsatilla nigricans in two cases, Sabina and Folliculinum in other two cases respectively. Since incidences of PCOS is increasing day-by-day such evidence-based medicinal studies…
How strong is the evidence?
Evidence Hub reads this as a case series, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Metformin as an adjuvant in breast cancer treatment
- Metformin Lysosomal Targeting: A Novel Aspect to Be Investigated for Metformin Repurposing in Neurodegenerative Diseases?
- Aberrant HSF1 signaling activation underlies metformin amelioration of myocardial infarction in mice
- Metformin induces ZFP36 by mTORC1 inhibition in cervical cancer-derived cell lines
- Protein Interaction Network for Identifying Vascular Response of Metformin (Oral Antidiabetic)
- Preventing Long COVID With Metformin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.